Advertisement

Topics

ABT-494 effective for patients with rheumatoid arthritis

08:45 EST 1 Dec 2016 | Medical Xpress

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor (anti-TNF) agent, according to two studies published online Nov. 28 in Arthritis & Rheumatology.

Original Article: ABT-494 effective for patients with rheumatoid arthritis

NEXT ARTICLE

More From BioPortfolio on "ABT-494 effective for patients with rheumatoid arthritis"

Quick Search
Advertisement
 

Relevant Topic

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...